Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
NHS England
NHS England
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Hi Tech Manufacturing
£10m research competition to tackle antimicrobial resistance
Move aims to encourage the development of innovative scientific approaches to addressing antimicrobial resistance
Research & Development
Professor Stephen Hawking gives NHS a stark warning
Professor Hawking spoke candidly at a public debate on his experiences as an NHS patient, the trials and tribulations of his physical health conditions and his views on its future
Regulatory
NICE decision sends “stark, negative signal” to UK life sciences
Changes announced by NICE and NHS will limit patient access to potentially life-saving medicines, says CEO of BIA
Regulatory
NHS England publishes authoritative information on biosimilar medicines
Document provides key clinical and non-clinical stakeholders with accessible information on how to support the appropriate use of all biological medicines
Subscribe now